Publications by authors named "A Willasch"

Claim this Profile
C
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP.
Andre Manfred Willasch, Claire Horgan, Christina Peters, Adriana Balduzzi, Jean-Hugues Dalle

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Julia Fekadu-Siebald, Emilia Salzmann-Manrique, Jan Robert Heusel, Andre Willasch, Fabian Hauck

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency.
Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald

Front Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Andrea Jarisch, Emilia Salzmann-Manrique, Jan Soerensen, Gudrun Sach, Eva Rettinger, Andre Willasch

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.
Laura M Moser, Julia Fekadu, André Willasch, Eva Rettinger, Jan Sörensen

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis